Related Experiment Video
Updated: May 17, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Biochemical markers of vascular calcification in elderly hemodialysis patients
Alvaro Osorio1, Esperanza Ortega, Jesús M Torres
1Vascular Surgery Unit, Sanitas Hospital, Madrid, Spain.
Insights
Chronic kidney disease (CKD) patients on hemodialysis show altered bone metabolism markers, including higher osteoprotegerin (OPG) and osteocalcin (OC), and lower fetuin-A. These changes are linked to vascular calcification and cardiovascular risks.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) is linked to mineral-bone metabolism disturbances, increasing vascular calcification, cardiovascular morbidity, and mortality.
- Understanding these metabolic alterations is crucial for managing cardiovascular complications in CKD patients.
Purpose of the Study:
- To identify specific serum markers associated with vascular calcification in elderly male and female hemodialysis CKD patients.
- To investigate alterations in bone formation and resorption parameters in this patient population.
Main Methods:
- Serum levels of osteoprotegerin (OPG), fetuin-A, tartrate-resistant acid phosphatase (TRACP-5b), bone-specific alkaline phosphatase (BAP), osteocalcin (OC), intact parathyroid hormone (iPTH), 25(OH)D(3), 1,25(OH)(2)D(3), calcium, and phosphorus were measured.
- Enzyme immunoassay, immunoenzymometric assay, ELISA, immunoradiometric assay, and photometric assay were employed for sample analysis.
Main Results:
- Elderly male and female hemodialysis CKD patients exhibited higher serum OPG, BAP, iPTH, phosphorus, and OC levels compared to controls.
- Conversely, serum 25(OH)D(3), 1,25(OH)(2)D(3), and fetuin-A levels were lower in CKD patients.
Conclusions:
- Bone formation and resorption parameters are significantly altered in elderly hemodialysis CKD patients.
- Elevated OPG and OC, along with reduced fetuin-A, are associated with vascular calcification and may contribute to cardiovascular events in CKD.
Abstract:
The increased vascular calcification, cardiovascular morbidity, and mortality in chronic kidney disease (CKD) patients has been associated with disturbances in mineral-bone metabolism. In order to determine markers of the vascular calcification frequently observed in these patients, blood samples of elderly male and female hemodialysis CKD patients were used to measure serum levels of: osteoprotegerin (OPG), total soluble receptor activator of nuclear factor-κB ligand (sRANKL), and fetuin-A by enzyme immunoassay; tartrate-resistant acid phosphatase (TRACP-5b), and bone-specific alkaline phosphatase (BAP) by immunoenzymometric assay; osteocalcin (OC) by ELISA; iPTH by immunoradiometric assay; 25(OH)D(3) and 1,25(OH)(2)D(3), by I(125) radioimmunoassay; and calcium and phosphorus by photometric assay. Serum OPG, BAP, iPTH, phosphorus, and OC levels were higher and serum 25(OH)D(3), 1,25(OH)(2)D(3), and fetuin-A levels lower in both male and female CKD patients than in their respective controls. Our results indicate that the bone formation and resorption parameters are altered in elderly male and female hemodialysis CKD patients. These changes may lead to vascular calcifications and cardiovascular complications, given that elevated OPG and OC levels and reduced fetuin-A levels are associated with cardiovascular events.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Hemodialysis III: Nursing Management
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction

